The need for biosimilars in the USA: Obstacles and solutions
Nigel Rulewski
Mohan Dewan
Increasing access with biosimilars
Steven Lehrer
Clinical trials for biosimilars: Principles and challenges
Heike Schoen
BCS: A scientific and regulatory tool in drug development process
Sunita Dahiya
Bioavailability enhancement techniques for BCS Class II and Class IV drugs
Jithan Venkata Aukunuru
Krishna Menon
Biosimilars in emerging markets: Regulatory and commercial considerations
Rodeina Challand
Journal of Bioanalysis & Biomedicine received 3099 citations as per Google Scholar report